Clinical Trial Update: Hydroxytyrosol and Vitamin E in Pediatric NASH [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial assessing hydroxytyrosol and vitamin E for nonalcoholic fatty liver disease (NAFLD) / nonalcoholic steatohepatitis (NASH) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Hydroxytyrosol (hydroxytyrosol)
• Vitamin E (alpha-tocopherol) (alpha-tocopherol)

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: NAFLD | Phase 3 | Status: COMPLETED